BioCorRx BICX
OTC BICX
$0.20 -0.01 (-4.76%)
At close: Oct 2, 2026 · 4:00 PM EDT

BioCorRx (BICX) Return on Equity [ROE] (2011 - 2025)

Updated

BioCorRx (BICX) reported Return on Equity [ROE] of -365.64% for Q2 2025.

Analysis

BioCorRx (BICX) Return on Equity [ROE] (2011 - 2025) Analysis & Trends

For FY2014, BioCorRx posted Return on Equity [ROE] of -1153.89%, down 990.45 percentage points from FY2013.

  • Return on Equity [ROE] has a three-year change of -1133.17 percentage points (FY2011 to FY2014).
  • By year, Return on Equity [ROE] came in at -163.44% in FY2013 (-143.75 pp), -19.68% in FY2012 (+1.03 pp) and -20.71% in FY2011.
  • The Q2 2025 figure ranks as the highest quarterly Return on Equity [ROE] since Q1 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.32%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 84.40%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 21.39%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 83.75%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -18.38%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.97%
10 BioCorRx 3.46 Mn 2.80 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -365.64%
Mar 31, 2015 -1,166.80%
Dec 31, 2014 -735.71%
Mar 31, 2013 -19.11%
Dec 31, 2012 -21.49%
Sep 30, 2012 -25.69%
Jun 30, 2012 -15.64%
Mar 31, 2012 -6.01%
Dec 31, 2011 -9.14%
Sep 30, 2011 -5.08%
API Access

BioCorRx Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BICX&period=max&api_key=YOUR_API_KEY